1989
DOI: 10.1128/iai.57.9.2903-2905.1989
|View full text |Cite
|
Sign up to set email alerts
|

Macrophage cell lines P388D1 and IC-21 stimulated with gamma interferon fail to inhibit the intracellular growth of Histoplasma capsulatum

Abstract: Histoplasma capsulatum, a facultative intracellular parasite of macrophages, grows within mononuclear cells of the P388D1 and IC-21 cell lines with a generation time comparable to that with which it grows in normal resident peritoneal macrophages (10 +/- 2 h). Recombinant murine gamma interferon (rMuIFN-gamma) activates P388D1 cells to express la antigens but not to inhibit the intracellular growth of H. capsulatum, alone or in combination with lipopolysaccharide. IC-21 cells also could not be activated to fun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
10
0

Year Published

1989
1989
2011
2011

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 10 publications
0
10
0
Order By: Relevance
“…Treatment of RAW 264.7 cells with rMuIFN--y results in the production of NO which correlates with the antihistoplasma activity of the cells (10). However, P388D, macrophages do not restrict the intracellular growth of H. capsulatum following treatment with rMuIFN-,y alone or in combination with LPS (13). The goal of this study was to measure iNOS expression in rMuIFN--y-treated RAW 264.7 and P388D, cells in an attempt to (i) explain the differences between the cell lines in the release NO and (ii) correlate the expression of iNOS with antihistoplasma activity.…”
mentioning
confidence: 99%
“…Treatment of RAW 264.7 cells with rMuIFN--y results in the production of NO which correlates with the antihistoplasma activity of the cells (10). However, P388D, macrophages do not restrict the intracellular growth of H. capsulatum following treatment with rMuIFN-,y alone or in combination with LPS (13). The goal of this study was to measure iNOS expression in rMuIFN--y-treated RAW 264.7 and P388D, cells in an attempt to (i) explain the differences between the cell lines in the release NO and (ii) correlate the expression of iNOS with antihistoplasma activity.…”
mentioning
confidence: 99%
“…The percent reductions recorded in rows 8, 9, 10, and 11 were made with results from MEM(-Met/Cys) supplemented with Cys as indicated. d This portion of the protocol (rows 1, 2, and 3) has been repeated a very large number of times with very similar results in the context of other experiments (23)(24)(25)(26)28). e The experiment recorded in this row was repeated one additional time with 0.4 mM cysteine.…”
mentioning
confidence: 68%
“…rMuIFN--y was supplied by Genentech, Inc., South San Francisco, Calif. The assay for intracellular growth was similar to that previously reported on a number of occasions (24,25,28).…”
mentioning
confidence: 93%
See 2 more Smart Citations